Cyclacel Pharmaceuticals ...

NASDAQ: CYCCP · Real-Time Price · USD
5.50
0.08 (1.51%)
At close: Aug 15, 2025, 2:47 PM
5.97
8.55%
After-hours: Aug 15, 2025, 07:30 PM EDT

Cyclacel Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
43K 420K n/a n/a
Cost of Revenue
6K n/a 32K 43K
Gross Profit
43K 420K -32K -43K
Operating Income
-12M -25.45M -27.66M -22.94M
Interest Income
12K 266K 210K 16K
Pretax Income
-11.99M -25.55M -25.91M -22.18M
Net Income
-11.21M -22.55M -21.2M -18.89M
Selling & General & Admin
5.39M 6.72M 7.38M 7.46M
Research & Development
6.66M 19.16M 20.27M 14.93M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
12.05M 25.87M 27.66M 22.39M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
12.05M 25.87M 27.66M 22.39M
Income Tax Expense
-782K -3M -4.72M -3.85M
Shares Outstanding (Basic)
8.31M 797.63K 750.38K 595.07K
Shares Outstanding (Diluted)
8.31M 797.63K 750.38K 595.07K
EPS (Basic)
-1.36 -28.67 -28.5 -32.1
EPS (Diluted)
-1.36 -28.67 -28.5 -32.1
EBITDA
-12M -25.42M -27.62M -22.69M
EBIT
-12M -25.45M -27.66M -22.73M
Depreciation & Amortization
6K 31K 32K 43K